Literature DB >> 33649870

Imaging and technologies for prostate cancer. Where are we now-where do we go?

Jean J M C H de la Rosette1, Rafael Sanchez Salas2, Art Rastinehad3, Thomas J Polascik4.   

Abstract

Entities:  

Year:  2021        PMID： 33649870     DOI： 10.1007/s00345-021-03641-5

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  14 in total

Review 1.  Low-risk Prostate Cancer: Identification, Management, and Outcomes.

Authors:  Marco Moschini; Peter R Carroll; Scott E Eggener; Jonathan I Epstein; Markus Graefen; Rodolfo Montironi; Christopher Parker
Journal:  Eur Urol       Date:  2017-03-18       Impact factor: 20.096

2.  Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.

Authors:  K J Tay; M J Scheltema; H U Ahmed; E Barret; J A Coleman; J Dominguez-Escrig; S Ghai; J Huang; J S Jones; L H Klotz; C N Robertson; R Sanchez-Salas; S Scionti; A Sivaraman; J de la Rosette; T J Polascik
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-03-28       Impact factor: 5.554

Review 3.  Prostate cancer multifocality, the index lesion, and the microenvironment.

Authors:  Rafael R Tourinho-Barbosa; Jean de la Rosette; Rafael Sanchez-Salas
Journal:  Curr Opin Urol       Date:  2018-11       Impact factor: 2.309

4.  Current state of image-guided focal therapy for prostate cancer.

Authors:  Rafael R Tourinho-Barbosa; Bradford J Wood; Andre Luis Abreu; Bruno Nahar; Toshitaka Shin; Selcuk Guven; Thomas J Polascik
Journal:  World J Urol       Date:  2020-05-22       Impact factor: 4.226

5.  Re: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

Authors:  Lara Rodríguez Sánchez; Petr Macek; Yann Barbé; Xavier Cathelineau; Rafael Sanchez-Salas
Journal:  Eur Urol       Date:  2020-05-06       Impact factor: 20.096

Review 6.  Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.

Authors:  B G Muller; W van den Bos; M Brausi; J J Fütterer; S Ghai; P A Pinto; I V Popeneciu; T M de Reijke; C Robertson; J J M C H de la Rosette; S Scionti; B Turkbey; H Wijkstra; O Ukimura; T J Polascik
Journal:  World J Urol       Date:  2015-01-06       Impact factor: 4.226

7.  Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.

Authors:  Lisa Moris; Marcus G Cumberbatch; Thomas Van den Broeck; Giorgio Gandaglia; Nicola Fossati; Brian Kelly; Raj Pal; Erik Briers; Philip Cornford; Maria De Santis; Stefano Fanti; Silke Gillessen; Jeremy P Grummet; Ann M Henry; Thomas B L Lam; Michael Lardas; Matthew Liew; Malcolm D Mason; Muhammad Imran Omar; Olivier Rouvière; Ivo G Schoots; Derya Tilki; Roderick C N van den Bergh; Theodorus H van Der Kwast; Henk G van Der Poel; Peter-Paul M Willemse; Cathy Y Yuan; Badrinath Konety; Tanya Dorff; Suneil Jain; Nicolas Mottet; Thomas Wiegel
Journal:  Eur Urol       Date:  2020-03-04       Impact factor: 20.096

Review 8.  Ablation energies for focal treatment of prostate cancer.

Authors:  Olivia Lodeizen; Martijn de Bruin; Scott Eggener; Sébastien Crouzet; Sangeet Ghai; Ioannis Varkarakis; Aaron Katz; Jose Luis Dominguez-Escrig; Sascha Pahernik; Theo de Reijke; Jean de la Rosette
Journal:  World J Urol       Date:  2018-06-25       Impact factor: 4.226

9.  Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

Authors:  Willemien van den Bos; Berrend G Muller; Hashim Ahmed; Chris H Bangma; Eric Barret; Sebastien Crouzet; Scott E Eggener; Inderbir S Gill; Steven Joniau; Gyoergy Kovacs; Sascha Pahernik; Jean J de la Rosette; Olivier Rouvière; Georg Salomon; John F Ward; Peter T Scardino
Journal:  Eur Urol       Date:  2014-01-13       Impact factor: 20.096

10.  Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus.

Authors:  Amir H Lebastchi; Arvin K George; Thomas J Polascik; Jonathan Coleman; Jean de la Rosette; Baris Turkbey; Bradford J Wood; Michael A Gorin; Abhinav Sidana; Sangeet Ghai; Kae Jack Tay; John F Ward; Rafael Sanchez-Salas; Berrend G Muller; Bernard Malavaud; Pierre Mozer; Sebastien Crouzet; Peter L Choyke; Osamu Ukimura; Ardeshir R Rastinehad; Peter A Pinto
Journal:  Eur Urol       Date:  2020-06-10       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.